An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

Part of paid clinical trials in Mobile, Alabama.

Sponsor
Qbtech AB
Study ID
NCT07217977
Status
Enrolling By Invitation

Conditions

  • Attention Deficit Disorder (ADD)
  • Attention Deficit Disorder With Hyperactivity (ADHD)

Eligibility Criteria

Sex
ALL
Age
6 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • observational study — OTHER
    observational study

Study Details

The current study will investigate if QbMobile can be used to improve the accuracy and objective identification of reduced ADHD symptoms in tests scores once treatment has been initiated.

Key Dates

Start date
Jan 15, 2025
Status verified
May 2026
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
175 participants (estimated)

Arms

  • Arm: ADHD

Primary Outcome Measure

Change in QbMobile Total Score from Baseline at Visit 3 and Visit 4 [ Time Frame: Baseline, Visit 3 (Week 2), and Visit 4 (Week 4) ]

Locations (7)

FacilityCityStateZIPSite coordinators
Focus-MDMobileAlabama36607-
Prodigy Psychiatric GroupSan JoseCalifornia95138-
Bokhari Medical ConsortiumLargoFlorida33770-
CCM Clinical Research GroupMiamiFlorida33133-
Nona Pediatric CenterOrlandoFlorida32829-
Godwin PsychiatryGoldsboroNorth Carolina27534-
MindWell Urgent CareDallasTexas75247-

Find similar trials in Mobile, AL

By research site
Focus-MD· Mobile, ALProdigy Psychiatric Group· San Jose, CABokhari Medical Consortium· Largo, FLCCM Clinical Research Group· Miami, FLNona Pediatric Center· Orlando, FLGodwin Psychiatry· Goldsboro, NC

Related Studies